Dis-Chem expects earnings surge of up to 21%
Dis-Chem Pharmacies Limited [JSE:DCP] has announced that it expects earnings per share (EPS) to be between ZAR136.5c and ZAR138.8c, and headline earnings per share (HEPS) to be between ZAR136.4c and ZAR138.7c for the twelve months ended 28 February 2025. This represents an increase of between 19% and 21% compared to the prior corresponding period in FY2024, when EPS was ZAR114.7c and HEPS was ZAR114.6c. The company will release its results on May 30, 2025, and a webcast will be available. The slides accompanying the presentation will be available on the Group's website in the Investors section at www.dischemgroup.com shortly before the commencement of the presentation.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when DIS-CHEM PHARMACIES LIMITED publishes news
Free account required • Unsubscribe anytime